PRECIGEN
LIVE

Serial Number

97819704

Owner

PRECIGEN, INC.

Attorney

Sarah P. Harrell

First Use Date

Jan 6, 2020

Filing Date

Mar 2, 2023

Add to watchlist:

No watchlists yet
View on USPTO

PRECIGEN Trademark

Serial Number: 97819704 • Registration: 7310349

PRECIGEN is a trademark filed by PRECIGEN, INC. on March 2, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services). The application is currently registered and active.

Owner Contact Info

PRECIGEN, INC. (55 trademarks)

1872 PRATT STREET, SUITE 1400
BLACKSBURG, VA 24060

Entity Type: 03

Trademark Details

Filing Date

March 2, 2023

Registration Date

February 20, 2024

First Use Anywhere

January 6, 2020

First Use in Commerce

January 6, 2020

Published for Opposition

December 5, 2023

Goods & Services

Chemical preparations for medical and veterinary purposes, namely, for gene and cell therapy for treating genetic disorders, cancers, rare diseases, infectious diseases, and immunological diseases and disorders; biochemical preparations for medical and veterinary purposes, namely, for gene and cell therapy for treating genetic disorders, cancers, rare diseases, infectious diseases, and immunological diseases and disorders; chemical reagents for medical and veterinary purposes, namely, for gene and cell therapy for treating genetic disorders, cancers, rare diseases, infectious diseases, and immunological diseases and disorders

Chemicals, biochemicals and reagents for use in industry and science; chemicals, biochemicals and reagents, namely, proteins for regulating, modifying or restricting gene expression; kits consisting primarily of proteins for regulating, modifying or restricting gene expression

Technology transfer services, namely, licensing of intellectual property

Medical services; Medical services, namely, genetic engineering, biopharmaceuticals and gene therapy services; Healthcare services, namely, treatment of patients with genetic disorders, cancers, rare diseases, infectious diseases, and immunological diseases and disorders; Medical services, namely, providing medical therapy treatments which are under development or have completed development for patients in the fields of oncology, rare diseases, metabolic disorders, and infectious diseases

Scientific research and development services in the field of medicine, pharmacology, immunology, biochemistry, cell biology, genetics, microbiology and virology; Scientific research in the field of healthcare; Therapeutic research of treatments in the fields of oncology, rare diseases, metabolic disorders, and infectious diseases which are under development or have completed development; Development of products being genetic therapies, biopharmaceuticals, and effectors to regulate, modulate, and characterize disease states; Development of tools in the nature of software and biotechnological processes to regulate, modulate, and characterize disease states; Research and development services for others in the field of biotechnology, namely, genetically engineering DNA, biological organisms, cells, viruses, pathogens, and special purpose cells for scientific, research, medical and laboratory use; Research and development services for others in the fields of genetics and biotechnology, namely, genetically engineering DNA, biological organisms, cells, viruses, pathogens, and special purpose cells for scientific, research, medical and laboratory use

Filing History

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Sep 24, 2025 ASCK
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 20, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 20, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 5, 2023 NPUB
PUBLISHED FOR OPPOSITION
Dec 5, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 15, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 30, 2023 CNSA
ASSIGNED TO EXAMINER
Oct 30, 2023 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Mar 23, 2023 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 22, 2023 NWOS
NEW APPLICATION ENTERED
Mar 6, 2023 NWAP